Concepedia

Glenn Crater

GC

Statistics

Publications

41

Citations

2K

H-Index

26

Active since

1987

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United Kingdom)

Wake Forest University

Theravance Biopharma (United States)

Glenn Crater is an author at GlaxoSmithKline (United States) specializing in chronic obstructive pulmonary disease, pulmonology, and medicine.

Publications per year

1987–2025

41

Publications

41

Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials

Marc Decramer, Antonio Anzueto, Edward Kerwin et al. · The Lancet Respiratory Medicine · 2014 · 233 citations

Medicine, Clinical Sciences, Pharmacology +14

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

Antonio Anzueto, Gary T. Ferguson, Greg Feldman et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2009 · 187 citations

Medicine, Internal Medicine, Pharmacotherapy +16

Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD

Bartolomé R. Celli, Glenn Crater, Sally Kilbride et al. · CHEST Journal · 2014 · 155 citations

Medicine, Pharmacology, Pharmacotherapy +8

Transient orientation of linear DNA molecules during pulsed-fleld gel electrophoresis

G. Holzwarth, Chad B. McKee, Susan Steiger et al. · Nucleic Acids Research · 1987 · 96 citations · Full text

Natural Sciences, Biophysics, Molecular Biology +13

Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol

David B. Badesch, Michael D. McGoon, Robin J. Barst et al. · The Journal of Rheumatology · 2009 · 86 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

1–5 of 41